Last reviewed · How we verify
potassium bromide
At a glance
| Generic name | potassium bromide |
|---|---|
| Target | Carbonic anhydrase 4 |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Monthly Replacement Orthokeratology for Myopia Control in Young Children (NA)
- Monthly Replacement Orthokeratology for Myopia Control in Existing Lens Wearers (NA)
- Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy (NA)
- Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
- Reversal of Acute β-Blocker Induced Bronchoconstriction (PHASE4)
- Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy (PHASE2,PHASE3)
- Assessment of Right Ventricular Volume in Tetralogy of Fallott (TOF) Patients
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- potassium bromide CI brief — competitive landscape report
- potassium bromide updates RSS · CI watch RSS
- portfolio CI